▲ Top longRank #1 of 50
REGNRegeneron Pharmaceuticals, Inc.
100/100
- Quality
- 69th
- Cheap
- 80th
- Sector
- Health Care
Long: #1 of 100 on Ray Dalio's long-minus-short score (0.554).
Loading the page…
“Balance risk across environments; follow the debt cycle.”
Not affiliated with Ray Dalio or Bridgewater Associates. This bot is a computer model Pick100 built from Ray Dalio's public statements and filings. Ray Dalio did not create, review or endorse it, its picks are not Ray Dalio's picks, and chatting with it is not talking to Ray Dalio. Legal notice
01How the bot thinks
Every Nasdaq 100 company is ranked on what the playbook cares about. Its long score, for how well a company fits:
The closest fits to the checklist: cheap on cash flow, little debt, cheap on earnings. Score near 100.
A separate short score hunts the worst fits: heavily indebted, expensive on cash flow, expensive on earnings. 1 sourced overlay from the investor's filings and statements add to either side. Re-ranked every week, at the close. Loss-makers are allowed long.
How far a company sits from the checklist: heavily indebted, expensive on cash flow, expensive on earnings.
Points added to a company's long or short score for what the investor has said or done, each with its source.
AAPL, MSFT, NVDA, AMZN, GOOGL, META, TSLAHe said the Magnificent 7 "have become rather expensive relative to what even optimists would say are the present value of the future cash flows" (Master Investor Podcast, July 2025). Source ↗
02Model output
Long: #1 of 100 on Ray Dalio's long-minus-short score (0.554).
Short: #1 of 50 shorts on Ray Dalio's long-minus-short score (-0.947).
03The bot's own results
5 of 8 right
The side its portfolio held on each day's stock. The bot doesn't pick: it holds all 100.
04The full book
Equal weight: $1,000 a position. Cheap and Quality are percentiles within the Nasdaq 100; a dash means the figure is missing.
05Method and limits
The 100 Nasdaq 100 companies. Anything outside it can't be held.
Long score: Cash-flow yield 3, Leverage 3, Earnings yield 2, Beta 2, Volatility 2, Net margin 1, Dividend yield 1. Short score: Leverage 3, Cash-flow yield 3, Earnings yield 2, Beta 2, Volatility 1, 6-month trend 1. Each a weighted blend of the company's percentile on each measure; the 50 with the best long minus short go long.
Always 50 long and 50 short. No market or rate bets. Changes fill at the next close.
Some tickers are missing figures and sit mid-pack on that measure. This profile is a draft and has not been reviewed yet.
Modeled on Ray Dalio's published approach. It is not Ray Dalio, and its picks are not Ray Dalio's. A free game on real closing prices, not investment advice.